Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

The Pathologist / Issues / 2022 / Aug / Business in Brief
Microbiology & Immunology Microbiology and Immunology Genetics and epigenetics Training and education Infectious Disease

Business in Brief

Discover some of the latest business news in pathology and laboratory medicine

By Liv Gaskill 08/29/2022 News 1 min read

Share

Express Diagnosis
 

KSL Beutner Laboratories has launched a highly accurate indirect immunofluorescence serum blood test to detect laminin 332, which is associated with the chronic autoimmune disease mucous membrane pemphigoid (1). The assay means that people with the condition won’t have to wait months for a diagnosis; the process could be reduced to 72 hours or less.

Two is Better than One
 

DNAnexus and Twist Bioscience have announced a collaboration to accelerate research and reduce the time it takes to design, validate, and commercialize novel next-generation sequencing-based tests (2). The partnership will enable customers to combine the integrated DNAnexus platform with two of Twist Bioscience’s products to simplify post-sequencing data analysis.

Credit: Image sourced from Pexels.com

Variant-Proof Plan
 

Funded by the Coalition for Epidemic Preparedness Innovations, a consortium partnership has been announced between ExcellGene, Bharat Biotech, and the University of Sydney (3). It aims to advance a new vaccine concept that provides cross-reactive protection against SARS-CoV-2 variants of concern and other betacoronaviruses.

Going Viral
 

Georgetown University has been awarded US$12.5 million from the National Science Foundation to establish a collaborative institute dedicated to researching and advancing education on viral emergence (4). The Verena Biology Integration Institute aims to develop cross-disciplinary research and train scientists at all career stages on the host-virus network, as well as on core scientific skills.

Do No Harm
 

The US FDA is reassessing its requirement for products under its jurisdiction to undergo animal testing – suggesting that new alternative methods, such as microphysiological sysems with cellular and computational models, may provide better results and bring products to market faster without the associated ethical concerns (5).

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

References

  1. 2022 AACC Annual Scientific Meeting Press Program (2022). Available at: https://bit.ly/3zXEzGQ.
  2. Business Wire (2022). Available at: https://bwnews.pr/3bYUay2.
  3. BC3 Newswire (2022). Available at: https://bit.ly/3K4zTnm.
  4. Georgetown University Medical Center (2022). Available at: https://bit.ly/3bXJtM5.
  5. Britt E. Erickson (2022). Available at: https://bit.ly/3QrpvbB.

About the Author(s)

Liv Gaskill

During my undergraduate degree in psychology and Master’s in neuroimaging for clinical and cognitive neuroscience, I realized the tasks my classmates found tedious – writing essays, editing, proofreading – were the ones that gave me the greatest satisfaction. I quickly gathered that rambling on about science in the bar wasn’t exactly riveting for my non-scientist friends, so my thoughts turned to a career in science writing. At Texere, I get to craft science into stories, interact with international experts, and engage with readers who love science just as much as I do.

More Articles by Liv Gaskill

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Context Matters in Cancer Biology
Microbiology and Immunology
Context Matters in Cancer Biology

December 27, 2021

1 min read

Akoya is leading the way with spatial phenotypic signatures – a novel class of biomarkers for predicting response to immunotherapy

What’s New in Infectious Disease? (December 2021)
Microbiology and Immunology
What’s New in Infectious Disease?

December 23, 2021

1 min read

The latest research and news on COVID-19 and the infectious disease landscape

Immunology Insights
Microbiology and Immunology
Immunology Insights

January 13, 2022

1 min read

The latest research in pathology and laboratory medicine

2021: A Laboratory Medicine Roundup
Microbiology and Immunology
2021: A Laboratory Medicine Roundup

January 18, 2022

3 min read

From transgender health care to the power of pathology podcasts, we take a look at our most popular articles of the last year

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.